Brian A. Markison joins Lantheus' board
by Brendon Nafziger, DOTmed News Associate Editor | September 12, 2012
Pharma executive Brian A. Markison has joined the board of directors of Lantheus Medical Imaging Inc., the imaging contrast agent company announced Monday.
Markison joined the board as part of his new position as "industry executive" with Avista Capital Partners, the $4 billion private equity firm that owns Lantheus. Avista separately announced Markison's hire on Monday.
Markison previously led Fougera Pharmaceuticals Inc., a dermatology drug firm, before it was bought by Novartis AG's generics branch, Sandoz. Before that, he helmed King Pharmaceuticals and worked for nearly two decades at Bristol-Myers Squibb, Lantheus said.
Lantheus is based in North Billerica, Mass.
Markison joined the board as part of his new position as "industry executive" with Avista Capital Partners, the $4 billion private equity firm that owns Lantheus. Avista separately announced Markison's hire on Monday.
Markison previously led Fougera Pharmaceuticals Inc., a dermatology drug firm, before it was bought by Novartis AG's generics branch, Sandoz. Before that, he helmed King Pharmaceuticals and worked for nearly two decades at Bristol-Myers Squibb, Lantheus said.
Servicing GE, Philips and Siemens CT equipment with OEM trained engineers
Numed, a well established company in business since 1975 provides a wide range of service options including time & material service, PM only contracts, full service contracts, labor only contracts & system relocation. Call 800 96 Numed for more info.
You Must Be Logged In To Post A CommentRegisterRegistration is Free and Easy. Enjoy the benefits of The World's Leading New & Used Medical Equipment Marketplace. Register Now! |
|
